The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Abstract
BACKGROUND AND AIMS: A general dysbiosis of the intestinal microbiota has been established in patients with Crohn's disease (CD), but a systematic characterisation of this dysbiosis is lacking. Therefore the composition of the predominant faecal microbiota of patients with CD was studied in comparison with the predominant composition in unaffected controls. Whether dysbiosis is present in relatives of patients CD was also examined. METHODS: Focusing on families with at least three members affected with CD, faecal samples of 68 patients with CD, 84 of their unaffected relatives and 55 matched controls were subjected to community fingerprinting of the predominant microbiota using denaturing gradient gel electrophoresis (DGGE). To analyse the DGGE profiles, BioNumerics software and non-parametric statistical analyses (SPSS V.17.0) were used. Observed differences in the predominant microbiota were subsequently confirmed and quantified with real-time PCR. RESULTS: Five bacterial species characterised dysbiosis in CD, namely a decrease in Dialister invisus (p=0.04), an uncharacterised species of Clostridium cluster XIVa (p = 0.03), Faecalibacterium prausnitzii (p < 1.3 × 10⁻⁵) and Bifidobacterium adolescentis (p = 5.4 × 10⁻⁶), and an increase in Ruminococcus gnavus (p = 2.1 × 10⁻⁷). Unaffected relatives of patients with CD had less Collinsella aerofaciens (p = 0.004) and a member of the Escherichia coli-Shigella group (p = 0.01) and more Ruminococcus torques (p = 0.02) in their predominant microbiota as compared with healthy subjects. CONCLUSION: Unaffected relatives of patients with CD have a different composition of their microbiota compared with healthy controls. This dysbiosis is not characterised by lack of butyrate producing-bacteria as observed in CD but suggests a role for microorganisms with mucin degradation capacity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although dysbiosis is associated with chronic inflammation and production of carcinogenic metabolites, 175, 176 there is limited evidence to support a direct link between specific intestinal bacteria, their virulence factors, and sporadic CRC.”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [175]
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Hampe, J., Franke, A., Rosenstiel, P. C., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., Vega, F. M. D. L., Briggs, J. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,951
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Low counts of Faecalibacterium prausnitzii in colitis microbiota
Sokol, H., Seksik, P., Furet, J. P., Firmesse, O., Nion-Larmurier, I., Beaugerie, L., Cosnes, J., Corthier, G., Marteau, P., & Doré, J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20903 · Cited by 1,275
Parkes, M., Barrett, J. C., Prescott, N. J., Tremelling, M., Anderson, C. A., Fisher, S. A., Roberts, R. G., Nimmo, E. R., Cummings, F. J. R., Soars, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2061 · Cited by 1,175
D’Haens, G., Geboes, K., Peeters, M., Baert, F., PENNINCKX, F. M., & Rutgeerts, P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70476-7 · Cited by 866
Self-citation
Cited by
Sorted by citations
Items 401–500 of 999
Dietary fibre confers therapeutic effects in a preclinical model of Huntington’s disease
Gubert, C., Kong, G., Costello, C., Adams, C. D., Masson, B. A., Qin, W., Choo, J. M., Narayana, V. K., Rogers, G. B., Renoir, T., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.12.023 · Cited by 45
Relationships Between Perinatal Interventions, Maternal-Infant Microbiomes, and Neonatal Outcomes
Valentine, G. C., Chu, D. M., Stewart, C. J., & Aagaard, K. M. (2018) · Clinics in Perinatology · doi:10.1016/j.clp.2018.01.008 · Cited by 45
Deng, Y., Li, M., Lü, M., Cong, L., Liu, Y., Zhang, B., He, C., Zheng, P., & Yuan, J. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0062 · Cited by 45
Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity
Meng, X. L., Zhou, H., Shen, H., Lufumpa, E., Li, X., Guo, B., & Li, B. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.006 · Cited by 46
Compositional and functional alterations of gut microbiota in patients with stroke
Xu, D., Wang, K., Yuan, L., Li, H., Xu, Y., Wei, L., Chen, L., Jin, K., & Lin, Q. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.08.045 · Cited by 45
Jansen, D., & Matthijnssens, J. (2023) · Viruses · doi:10.3390/v15010173 · Cited by 43
Gut microbiota and cardiac arrhythmia
Fan, H., Liu, X., Ren, Z., Fei, X., Luo, J., Yang, X., Xue, Y., Zhang, F., & Liang, B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1147687 · Cited by 48
Improvement of inflammatory bowel disease by lactic acid bacteria-derived metabolites: a review
Guo, W., Mao, B., Tang, X., Zhang, Q., Zhao, J., Zhang, H., Chen, W., & Cui, S. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2291188 · Cited by 46
Functional host-specific adaptation of the intestinal microbiome in hominids
Rühlemann, M. C., Bang, C., Gogarten, J. F., Hermes, B. M., Groussin, M., Waschina, S., Poyet, M., Ulrich, M., Akoua-Koffi, C. G., Deschner, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44636-7 · Cited by 50
Meta-omics in Inflammatory Bowel Disease Research: Applications, Challenges, and Guidelines
Valles‐Colomer, M., Darzi, Y., Vieira‐Silva, S., Falony, G., Raes, J., & Joossens, M. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw024 · Cited by 46
Self-citationDysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives
Picco, M. F. (2011) · Yearbook of Gastroenterology · doi:10.1016/j.ygas.2011.07.080 · Cited by 44
Ijaz, U. Z., Quince, C., Hanske, L., Loman, N. J., Calus, S., Bertz, M., Edwards, C. A., Gaya, D. R., Hansen, R., McGrogan, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172605 · Cited by 44
Hart, M. L., Ericsson, A. C., Lloyd, K. C. K., Grimsrud, K., Rogala, A. R., Godfrey, V., Nielsen, J. N., & Franklin, C. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-28448-0 · Cited by 41
Danshen can interact with intestinal bacteria from normal and chronic renal failure rats
Cai, H.-D., Su, S., Li, Y., Zhu, Z., Guo, J., Zhu, K. Y., Guo, S., Qian, D., & Duan, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.047 · Cited by 44
Wang, Z., Xu, C., Liu, Y., Wang, X., Zhang, L., Li, M., Zhu, S., Xie, Z., Wang, P., Duan, L.-P., et al. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000192 · Cited by 45
The microbiome in spondyloarthritis
Bréban, M., Beaufrère, M., & Glatigny, S. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101495 · Cited by 44
Zhang, F., Ferrero, M., Dong, N., D’Auria, G., Reyes‐Prieto, M., Herreros‐Pomares, A., Fariñas, S. C., Duréndez-Saéz, E., Aparisi, F., Blasco, A., et al. (2021) · Cancers · doi:10.3390/cancers13112514 · Cited by 45
Differential clustering of fecal and mucosa‐associated microbiota in ‘healthy’ individuals
Carstens, A., Roos, A., Andréasson, A., Magnuson, A., Agréus, L., Halfvarson, J., & Engstrand, L. G. (2018) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12688 · Cited by 43
The gut microbiota heterogeneity and assembly changes associated with the IBD
Sun, Y., Li, L., Yao, X. Y., Li, W., Wang, K., Wang, L., Miao, Y., & Ma, S. (2019) · Scientific Reports · doi:10.1038/s41598-018-37143-z · Cited by 43
Li, M., Zhu, L., Xie, A., & Yuan, J. (2014) · Inflammation · doi:10.1007/s10753-014-0019-7 · Cited by 43
Gut-microbiota-on-a-chip: an enabling field for physiological research
Trujillo-de Santiago, G., Lobo-Zegers, M. J., Montes-Fonseca, S. L., Zhang, Y. S., & Alvarez, M. M. (2018) · Microphysiological Systems · doi:10.21037/mps.2018.09.01 · Cited by 43
Bifidobacterium adolescentis – a beneficial microbe
Leser, T. D., & Baker, A. (2017) · Beneficial Microbes · doi:10.1163/18762891-20230030 · Cited by 53
Banaszkiewicz, A., Kadzielska, J., Gawrońska, A., Pituch, H. M., Obuch-Woszczatyński, P., Albrecht, P., Młynarczyk, G., & Radzikowski, A. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.08.018 · Cited by 43
Kovatcheva‐Datchary, P., Tremaroli, V., & Bäckhed, F. (2013) · Springer eBooks · doi:10.1007/978-3-642-30144-5_87 · Cited by 46
He, Q., Wang, L., Wang, F., & Li, Q. (2014) · Zebrafish · doi:10.1089/zeb.2013.0917 · Cited by 42
Cutaneous Nod2 Expression Regulates the Skin Microbiome and Wound Healing in a Murine Model
Williams, H., Crompton, R. A., Thomason, H. A., Campbell, L., Singh, G., McBain, A. J., Cruickshank, S. M., & Hardman, M. J. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.029 · Cited by 43
Lunken, G., Tsai, K., Schick, A., Lisko, D. J., Cook, L. E., Vallance, B. A., & Jacobson, K. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.06.011 · Cited by 42
Oh, B. S., Choi, W. J., Kim, J., Ryu, S. W., Yu, S. Y., Lee, J., Park, S., Kang, S. W., Lee, J., Jung, W. Y., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.736343 · Cited by 41
Al-Amrah, H., Saadah, O. I., Mosli, M. H., Annese, V., Al-Hindi, R. R., Edris, S., Alshehri, D., Alatawi, H. A., Alatawy, M., & Bahieldin, A. (2023) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_368_22 · Cited by 41
Garavaglia, B., Vallino, L., Amoruso, A., Pane, M., Ferraresi, A., & Isidoro, C. (2024) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2024.100056 · Cited by 48
HIF1A regulates xenophagic degradation of adherent and invasiveEscherichia coli(AIEC)
Mimouna, S., Bazin, M., Mograbi, B., Darfeuille–Michaud, A., Brest, P., Hofman, P. M., & Vouret‐Craviari, V. (2014) · Autophagy · doi:10.4161/15548627.2014.984275 · Cited by 44
Bacteria in the pathogenesis of inflammatory bowel disease
Flanagan, P. K., Campbell, B. J., & Rhodes, J. M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391067 · Cited by 41
The effect of NOD2 on the microbiota in Crohn's disease
Lauro, M. L., Burch, J. M., & Grimes, C. L. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.028 · Cited by 49
Pig models on intestinal development and therapeutics
Yin, L., Yang, H., Li, J., Li, Y., Ding, X., Wu, G., & Yin, Y. (2017) · Amino Acids · doi:10.1007/s00726-017-2497-z · Cited by 41
Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case series
Agrawal, G. K., Clancy, A. K., Huynh, R., & Borody, T. J. (2020) · Gut Pathogens · doi:10.1186/s13099-020-00355-8 · Cited by 41
Nelson, A., Stewart, C. J., Kennedy, N. A., Lodge, J. K., Tremelling, M., Probert, C. S., Parkes, M., Mansfield, J. C., Smith, D., Hold, G. L., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa220 · Cited by 43
Collinsella aerofaciens Produces a pH-Responsive Lipid Immunogen
Kwon, J., Bae, M., Szamosvári, D., Cassilly, C. D., Bolze, A. S., Jackson, D. R., Xavier, R. J., & Clardy, J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c00250 · Cited by 40
Hedin, C. R. H., Stagg, A. J., Whelan, K., & Lindsay, J. O. (2011) · Gut · doi:10.1136/gut.2011.238568 · Cited by 40
Cook, L. E., Lisko, D. J., Wong, M. Q., García, R., Himmel, M. E., Seidman, E. G., Bressler, B. L., Levings, M. K., & Steiner, T. S. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.11.012 · Cited by 42
Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis
Silbergleit, M., Vasquez, A. A., Miller, C. J., Sun, J., & Kato, I. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.02.004 · Cited by 40
Melton, S. L., Taylor, K. M., Gibson, P. R., & Halmos, E. P. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17451 · Cited by 39
Patients with Inflammatory Bowel Disease Exhibit Dysregulated Responses to Microbial DNA
Hotte, N., Salim, S. Y., Tso, R., Albert, E. J., Bach, P. V., Walker, J. W. T., Dieleman, L. A., Fedorak, R. N., & Madsen, K. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037932 · Cited by 38
Phenotypic variation in Blastocystis sp. ST3
Ragavan, N. D., Govind, S. K., Chye, T. T., & Mahadeva, S. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-404 · Cited by 40
Li, Q., Wang, C., Zhang, Q., Tang, C. X., Li, N., Ruan, B., & Li, J. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.09.017 · Cited by 39
Strain, C., Collins, K. C., Naughton, V. R., McSorley, E. M., Stanton, C., Smyth, T. J., Soler‐Vila, A., Rea, M. C., Ross, R. P., Cherry, P., et al. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-01909-6 · Cited by 43
Paola, M. D., Rizzetto, L., Stefanini, I., Vitali, F., Massi-Benedetti, C., Tocci, N., Romani, L. R., Ramazzotti, M., Lionetti, P., Filippo, C. D., et al. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100036 · Cited by 39
Prebiotics and Inflammatory Bowel Disease
Rasmussen, H. E., & Hamaker, B. R. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.08.004 · Cited by 38
Emerging concepts in non-invasive monitoring of Crohn’s disease
Marlicz, W. M., Skonieczna‐Żydecka, K., Dabos, K. J., Łoniewski, I., & Koulaouzidis, A. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818769076 · Cited by 38
Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers
Rojas-Feria, M., Romero-García, T., Caballero-Rico, J. Á. F., Pastor‐Ramírez, H., Avilés-Recio, M., Castro‐Fernández, M., Chueca, N., Romero‐Gómez, M., García, F., Grande, L., et al. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i46.5223 · Cited by 40
Metabolomics activity screening of T cell–induced colitis reveals anti-inflammatory metabolites
Montenegro-Burke, J. R., Kok, B. P., Guijas, C., Domingo-Almenara, X., Moon, C., Galmozzi, A., Kitamura, S., Eckmann, L., Sáez, E., Siuzdak, G. E., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abf6584 · Cited by 42
Palmieri, O., Castellana, S., Biscaglia, G., Panza, A., Latiano, A., Fontana, R., Guerra, M., Corritore, G., Latiano, T. P., Martino, G., et al. (2021) · Cells · doi:10.3390/cells10113243 · Cited by 37
Holman, J. M., Hurd, M., Moses, P. L., Mawe, G. M., Zhang, T., Ishaq, S. L., & Li, Y. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109238 · Cited by 40
Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease
Sauceda, C., Bayne, C. F., Sudqi, K., González, A., Dulai, P. S., Knight, R. D., Gonzalez, D. J., & Gonzalez, C. G. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2154092 · Cited by 40
Xu, Y., Zhu, W., & Guo, Z. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i48.6888 · Cited by 40
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD
Liang, D., Liu, H., Jin, R., Feng, R., Wang, J., Qin, C., Zhang, R., Chen, Y., Zhang, J., Teng, J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2276296 · Cited by 38
The shifting interface between IBS and IBD
Spiller, R. E., & Lam, C. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.009 · Cited by 38
The microbiota regulates susceptibility to Fas-mediated acute hepatic injury
Celaj, S., Gleeson, M. W., Deng, J., O’Toole, G. A., Hampton, T. H., Toft, M., Morrison, H. G., Sogin, M. L., Putra, J., Suriawinata, A. A., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.93 · Cited by 38
Noğay, N. H., & Nahikian-Nelms, M. L. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1630894 · Cited by 39
Johnson, A. M., Harmsen, W. S., Aniwan, S., Tremaine, W. J., Dayyeh, B. K. A., & Loftus, E. V. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab097 · Cited by 36
The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn’s Disease
Knez, E., Wzorek, K., Folwarski, M., Kaźmierczak-Siedlecka, K., Stachowska, L., Przewłócka, K., Stachowska, E., & Skonieczna‐Żydecka, K. (2021) · Nutrients · doi:10.3390/nu13072125 · Cited by 41
New insight into the gut microbiome through metagenomics
Nielsen, J., & Ji, B. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s57215 · Cited by 36
Dysbiosis of the fecal microbiota in the TNBS-induced Crohn’s disease mouse model
He, Q., Li, X., Liu, C., Su, L., Xia, Z., Li, X., Li, Y., Li, L., Yan, T., Feng, Q., et al. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7205-x · Cited by 36
Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis
Sjöberg, F., Barkman, C., Nookaew, I., Östman, S., Adlerberth, I., Saalman, R., & Wold, A. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186178 · Cited by 35
Current, experimental, and future treatments in inflammatory bowel disease: a clinical review
Hvas, C. L., Bendix, M., Dige, A. K., Dahlerup, J. F., & Agnholt, J. S. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1469144 · Cited by 37
Treatments of inflammatory bowel disease toward personalized medicine
Kim, K., Kim, J., Kim, W.-H., Min, H., & Choi, C. H. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01318-6 · Cited by 36
Lacroix, V., Cassard, A., Mas, E., & Barreau, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011255 · Cited by 36
The gut microbiome as mediator between diet and its impact on immune function
Shi, H., ter Horst, R., Nielen, S., Bloemendaal, M., Jaeger, M., Joosten, I., Koenen, H. J. P. M., Joosten, L. A. B., Schweren, L., Vásquez, A. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08544-y · Cited by 36
Lactobacillus paracasei CNCM I-5220-derived postbiotic protects from the leaky-gut
Algieri, F., Tanasković, N., Rincón, C. L. C., Notario, E., Braga, D., Pesole, G., Rusconi, R., Penna, G., & Rescigno, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1157164 · Cited by 43
Li, J., Liu, F., Luo, Y., Wijeyesekera, A., Wang, S., Chen, X., Lv, Y., Jin, J., Sheng, H.-F., Wang, G., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04189-6 · Cited by 39
Systems biology in inflammatory bowel diseases
Polytarchou, C., Κούκος, Γ., & Iliopoulos, D. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000081 · Cited by 35
Sovran, B., Lu, P., Loonen, L. M. P., Hugenholtz, F., Belzer, C., Stolte, E. H., Boekschoten, M. V., van Baarlen, P., Smidt, H., Kleerebezem, M., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000688 · Cited by 34
Dunn, K. A., Moore-Connors, J., MacIntyre, B., Stadnyk, A. W., Thomas, N. A., Noble, A. J., Mahdi, G., Rashid, M., Otley, A. R., Bielawski, J. P., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000949 · Cited by 36
Gut environmental factors and multiple sclerosis
Miyake, S., & Yamamura, T. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.07.015 · Cited by 36
Assadsangabi, A., Evans, C. A., Corfe, B. M., & Lobo, A. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1426954 · Cited by 35
Metabolic networks of the human gut microbiota
Selber‐Hnatiw, S., Sultana, T., Tse, W., Abdollahi, N., Abdullah, S., Rahbani, J. A., Alazar, D., Alrumhein, N. J., Aprikian, S., Arshad, R., et al. (2019) · Microbiology · doi:10.1099/mic.0.000853 · Cited by 38
Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease
Yan, P., & Li, J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000718 · Cited by 35
Labourel, A., Parrou, J., Deraison, C., Mercier‐Bonin, M., Lajus, S., & Potocki-Véronèse, G. (2023) · Essays in Biochemistry · doi:10.1042/ebc20220153 · Cited by 36
Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier
Akuzum, B., & Lee, J. (2022) · Immune Network · doi:10.4110/in.2022.22.e46 · Cited by 36
The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever
Silverman, G. J., Azzouz, D. F., Gisch, N., & Amarnani, A. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01071-8 · Cited by 39
Olteanu, G., Pană, M.-A., Busnatu, Ș., Lupuliasa, D., Neacșu, S. M., Mititelu, M., Musuc, A. M., Ioniță-Mîndrican, C.-B., & Boroghină, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105561 · Cited by 36
Zachos, K. A., Gamboa, J. A., Dewji, A. S., Lee, J., Brijbassi, S., & Andreazza, A. C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1428242 · Cited by 35
Perturbation of the Human Microbiome as a Contributor to Inflammatory Bowel Disease
Missaghi, B., Barkema, H. W., Madsen, K., & Ghosh, S. K. (2014) · Pathogens · doi:10.3390/pathogens3030510 · Cited by 35
Swafford, D., Shanmugam, A., Ranganathan, P. V., Hussein, M. S., Koni, P. A., Prasad, P. D., Thangaraju, M., & Manicassamy, S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701086 · Cited by 34
Liu, F., Wang, T. T. Y., Tang, Q., Xue, C., Li, R. W., & Wu, V. C. H. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900455 · Cited by 34
Sarrabayrouse, G., Elías, A. D., Yáñez, F., Mayorga, L., Varela, E., Bartoli, C., Casellas, F., Borruel, N., Guise, C. H.-D., Machiels, K., et al. (2021) · mSystems · doi:10.1128/msystems.01277-20 · Cited by 35
Self-citationShort chain fatty acids (SCFAs) improves TNBS-induced colitis in zebrafish
Morales, C., do Amaral, M. A., Xavier, I. K., Padovani, B. N., Paredes, L. C., Takiishi, T., Lopes‐Ferreira, M., Lima, C., Colombo, A., & Câmara, N. O. S. (2021) · Current Research in Immunology · doi:10.1016/j.crimmu.2021.08.003 · Cited by 37
Basile, A., Heinken, A., Hertel, J., Smarr, L. L., Li, W., Treu, L., Valle, G., Campanaro, S., & Thiele, I. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2226921 · Cited by 32
Zeamer, A. L., Salive, M.-C., An, X., Beaudoin, F. L., House, S. L., Stevens, J. S., Zeng, D., Neylan, T. C., Clifford, G. D., Linnstaedt, S. D., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02643-8 · Cited by 34
Zhang, J., Huang, Y.-J., Trapečar, M., Wright, C. W., Schneider, K., Kemmitt, J., Hernandez‐Gordillo, V., Yoon, J. Y., Poyet, M., Alm, E. J., et al. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00501-z · Cited by 33
The role of goblet cells in Crohn’ s disease
Wang, Z., & Shen, J. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01220-w · Cited by 35
Host–pathobiont interactions in Crohn’s disease
Caruso, R., Lo, B. C., Chen, G., & Núñez, G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00997-y · Cited by 35
Uncovering a novel molecular mechanism for scavenging sialic acids in bacteria
Bell, A., Severi, E., Lee, M., Monaco, S., Latousakis, D., Angulo, J., Thomas, G. H., Naismith, J. H., & Juge, N. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014454 · Cited by 35
Impact of bacterial infection and intestinal microbiome on colorectal cancer development
Sun, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001979 · Cited by 35
Matrix metalloproteinase 9 contributes to gut microbe homeostasis in a model of infectious colitis
Rodrigues, D. M., Sousa, A. J., Hawley, S. P., Vong, L., Gareau, M. G., Kumar, S. A., Johnson‐Henry, K. C., & Sherman, P. M. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-105 · Cited by 33
Metabolic independence drives gut microbial colonization and resilience in health and diseasePreprint
Watson, A. R., Füssel, J., Veseli, I., DeLongchamp, J. Z., Silva, M., Trigodet, F., Lolans, K., Shaiber, A., Fogarty, E. C., Runde, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.02.433653 · Cited by 33
Park, J., Song, W., Lee, J., Jo, S.-H., Lee, J., Jeon, H., Kwon, J.-E., Kim, Y., Baek, J., Kim, M. G., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.825399 · Cited by 34
Ghosal, S., Bag, S., Rao, S. R., & Bhowmik, S. (2024) · RSC Advances · doi:10.1039/d4ra04544k · Cited by 37
Lu, H., Zhang, C., Qian, G., Hu, X., Zhang, H., Chen, C., Liang, W., Gao, H., Yang, Y., & Li, L. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-359 · Cited by 32
Impact of Obesity on the Management of Inflammatory Bowel Disease.
Johnson, A. M., & Loftus, E. V. (2020) · PubMed Central · Cited by 32
Watanabe, S., Kameoka, S., Shinozaki, N. O., Ryuichi, K. U. B. O., Nishida, A., Kuriyama, M., & Takeda, A. (2021) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2020-038 · Cited by 37
Metadata
- Authors
- Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Ghent University (BE)
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2011-01-05
- Volume
- 60
- Issue
- 5
- Pages
- 631-637
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2139327060
- Semantic Scholar
- 3c76b951197740ae02ffa2ef816767ede9de1b85
- Cited by
- 1,063
- References
- 47
- Citations by year
- 2026: 30 · 2025: 67 · 2024: 88 · 2023: 91 · 2022: 73 · 2021: 103 · 2020: 95 · 2019: 81 · 2018: 65 · 2017: 60 · 2016: 74 · 2015: 56 · 2014: 68 · 2013: 57 · 2012: 34
- FWCI
- 23.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Keywords
- Crohn's disease, fecal microbiota, dysbiosis, gut microbiota composition, unaffected relatives, Dialister invisus, Faecalibacterium prausnitzii, Bifidobacterium adolescentis, Ruminococcus gnavus, Ruminococcus torques, Collinsella aerofaciens, Clostridium cluster XIVa, mucin degradation, butyrate-producing bacteria, familial aggregation
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bacteria, Crohn Disease, DNA, Bacterial, Feces, Female, Humans, Male, Middle Aged, Symbiosis, Case-Control Studies, Reverse Transcriptase Polymerase Chain Reaction, Metagenome, Young Adult, Denaturing Gradient Gel Electrophoresis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
